Basic Information
ID: ALA4426704
Type: ADME
Description: Drug level in rat hepatocytes treated with 25-Chloro-18-methyl-13,14,17,20,22,23-hexahydro-1H,7H-15,19-methano-8,12-(metheno)-4,6,2,14,15,22-benzodioxatetraazacyclopentacosine-3,7,21,28(1H,16H)-tetrone assessed as esterase-mediated compound formation at 4 uM after 40 mins by ultraperformance liquid chromatographic method
Format: BAO_0000219
Organism: Rattus norvegicus
Target: Unchecked(ALA612545)
Document: ALA4425130
Drug level in rat hepatocytes treated with 25-Chloro-18-methyl-13,14,17,20,22,23-hexahydro-1H,7H-15,19-methano-8,12-(metheno)-4,6,2,14,15,22-benzodioxatetraazacyclopentacosine-3,7,21,28(1H,16H)-tetrone assessed as esterase-mediated compound formation at 4 uM after 40 mins by ultraperformance liquid chromatographic method: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4426704
Drug metabolism
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 30.03 | -0.18 | -0.18 |
| 470.96 | 2.76 | 2.76 |